UNSPSC 51144003: Azalanstat

This classification denotes an anti-lipidemic agent with the molecular formula C22H24CLN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 2NL79NI1WS chemically known as 1-(((2s,4s)-4-(((p-aminophenyl)thio)methyl)-2-(p-chlorophenethyl)-1,3-dioxolan-2-yl)methyl)imidazole, but more commonly known as azalanstat, which bears US NIH Compound Identifier 60876. European Medicines Agency schedules Azalanstat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05630MIG.

UNSPSC 51144003 Azalanstat, a Commodity code, does not align with the state and local procurement activity posted under it. The three recent opportunities tagged to this code solicit naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which are azalanstat, an antihistamine pharmaceutical. The code shows little relevant recent activity; the mismatch between the code's nominal scope and the actual work being procured suggests either a tagging error in the source data or discontinued market demand for azalanstat specifically within state and local government purchasing.

The issuing bodies and geographic spread reflect pharmaceutical procurement across multiple jurisdictions rather than azalanstat demand. Seminole County, Florida (IFB 60459723LAS, response due July 26, 2023) solicited naloxone and drug deactivation systems through competitive bid; the Texas Health and Human Services Commission (RFI HHS0017013, response due April 3, 2026) issued a Request for Information on direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (RFP S1070000015802, response due March 26, 2026) sought generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon. Without recent solicitations explicitly naming azalanstat, this code does not present active procurement opportunity.